X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 11c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.72), $0.11 worse than the analyst estimate of ($0.61).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Worried the AI trade has gone too far? Evercore likes these 4 stocks
• NVE Corporation names new CEO and expands board to seven members